Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Condition:   Colorectal Cancer Interventions:   Drug: Bevacizumab Injection [Avastin];   Drug: Oxaliplatin;   Drug: Capecitabine;   Biological: PD1-T cells Sponsor:   Tianjin Medical University Cancer Institute and Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials